検索結果

Meetings of the Minds | Research & Development | SENJU Pharmaceutica

羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study Tomoyuki Wada, PhD 1; Stephen C Pflugfelder, MD 2; Kazunori Omats...